Founded in 2013 and headquartered in San Sebastián, Irisbond designs and sells AI-based eye-tracking assistive communication devices for people with conditions such as ALS or cerebral palsy, serving over 1,100 users through more than 100 hospitals across 15 Spanish regions. In June 2026 COFIDES granted Irisbond a 1.2 million euro loan from its Social Impact Fund (FIS) to supply eye-tracking devices to patients under the Madrid public health service (SERMAS).